Personal research profile

Research profile

In these times, one topic takes center stage: the Covid-19 pandemic. It is also leading to a greater focus on science and growing interest in our work. Despite this exceptional situation, we must not forget that there are many other diseases that turn the lives of numerous people upside down every year and often end in tragedies.

Depression is one such disease. Current figures show that depression is on the rise worldwide. Unfortunately, mental illness is still a taboo subject in many parts of society, causing lots of people to suppress their problems. As a result, it must be assumed that the official figures, which only reflect medically diagnosed depression, greatly underestimate the reality.
Depression is frequently reported as an adverse drug reaction and appears in countless medication package inserts. Many of these drugs, such as oral contraceptives, have become an integral part of everyday life, while others are misused by athletes to enhance performance.
Given the fatal consequences that depression brings to the affected person and his or her personal environment, as well as the immense burden it places on social systems, the research I am conducting into possible risk factors and pathophysiological triggers of depression is highly relevant.

Expertise related to UN Sustainable Development Goals

In September 2015, 193 UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):

  • SDG 3 - Good Health and Well-being


Dive into the research topics where Sam Thilmany is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
  • 1 Similar Researchers' profiles